Oramed Pharmaceuticals (ORMP) Receivables - Net (2011 - 2015)

Oramed Pharmaceuticals (ORMP) posted Receivables - Net of $33000.0 for Q2 2015, down 57.69% on a QoQ basis from $78000.0 in Q3 2014.

Oramed Pharmaceuticals (ORMP) Receivables - Net (2011 - 2015) Analysis & Trends

Oramed Pharmaceuticals' Receivables - Net history runs 5 years deep, the most recent figure standing at $33000.0 for Q2 2015.

Quarterly Receivables - Net changed N/A year-over-year to $33000.0 in Q2 2015, while the trailing twelve-month figure through May 2015 was $33000.0 (changed N/A YoY) and the FY2014 annual result came in at $78000.0, changed N/A from the prior year.
Receivables - Net was $33000.0 for Q2 2015 at Oramed Pharmaceuticals, down from $78000.0 in the prior quarter.
Across five years, Receivables - Net topped out at $542891.0 in Q3 2011 and bottomed at $33000.0 in Q2 2015.
A 5-year average of $185907.1 and a median of $86845.5 in 2011 frame the typical range for Receivables - Net.
Annual changes were most pronounced in 2012 — Receivables - Net sank 83.85% — and 2013, when it surged 842.3%.
Oramed Pharmaceuticals' Receivables - Net stood at $86000.0 in 2011, then decreased by 11.69% to $75950.0 in 2012, then jumped by 339.39% to $333719.0 in 2013, then plunged by 76.63% to $78000.0 in 2014, then sank by 57.69% to $33000.0 in 2015.
Business Quant data shows ORMP's Receivables - Net at $33000.0 in Q2 2015, $78000.0 in Q3 2014, and $333719.0 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Oramed Pharmaceuticals	170.25 Mn	170.25 Mn	-

Download Data